Golo Ahlenstiel

Professor

MBBS/MD/PhD/FRACP

g.ahlenstiel@westernsydney.edu.au

The Storr Liver Centre

Liver Immunology Group

Currently open to PHD and Honours students in the topic areas of:

Immunology

Innate immunity

Liver disease

Viral hepatitis

Cancer immunology

Golo Ahlenstiel

Biography

Professor Golo Ahlenstiel is Chair of Medicine at Blacktown Clinical School, Western Sydney University, and Clinical Network Director for Specialty Medicine in Western Sydney Local Health District.

After completing his medical degree and MD/PhD at the University of Bonn in Germany, Golo Ahlenstiel received research fellowships from the National Institutes of Health (NIH, USA) and the German Research Foundation to pursue liver immunology research at the National Institutes of Health, Bethesda, MD, USA in 2004. In 2009 Golo Ahlenstiel moved to Sydney where he completed basic physician and advanced training in Gastroenterology/Hepatology in WSLHD in 2013. In 2014 he was appointed Associate Professor at the University of Sydney and full time staff specialist in Gastroenterology/Hepatology at Westmead Hospital. In 2017, he moved to Blacktown-Mount Druitt Hospital as Chair of Medicine.

He is an academic hepatologist with over 7000 career citations. He is Faculty at the Westmead Institute for Medical Research, and member of the Liver Faculty Executive of GESA, and the TRIPLE III Executive of SPHERE / Maridulu Budyari Gumal. He leads active translational research programs in liver immunology at the Westmead Institute, as well as metabolic disease., liver cirrhosis and immunotherapy of cancer at Blacktown Clinical School.

Research interests

Liver Immunology, Liver cirrhosis and portal hypertension, Innate immunity, Cancer immunology, Chronic liver disease

Adjunct roles

Chair of Medicine. Blacktown Clinical School Western Sydney University
Network Director Specialty Medicine Western Sydney LHD
Head of Department, Gastroenterology & Hepatology Blacktown Hospital

Current grants

Bristol Myers Squibb Investigator Sponsored Research Grant 2021-2024 Risk factors of liver and gastrointestinal adverse events in cancer patients treated with Ipilimumab + Nivolumab (CA209-6KR).
MRFF - Optimising the Clinical Use of Immunoglobulins 2022-2027 antiCD20 treatment to rationalise the use of IV/SC-IG in CIDP
MRFF- COVID-19 Health Impacts and Vaccination Schedules 2022-2027 Comparing Immunisation-boosting Regimens for COVID-19 Upon Initiation of immunosuppressive Therapies (CIRCUIT Study)

Affiliations

GESA, Liver Faculty, WSLHD, TRIPLE III Executive of SPHERE / Maridulu Budyari Guma

Professional Associations and Organisations

2021/22 WSLHD/ICCH Senior Medical Advisor COVID-inTouch
2014-22 USYD/Westmead Clinical School Associate Professor (conjoin/hon)
2020-21 WSLHD/BMDH Acting Director Division 3
2014-17 WSLHD/Westmead Staff Specialist Gastroenterology

Awards and recognition

Fellow GESA (FGESA) 2022
WSLHD Award for Collaborative Leadership 2022
NSW Public Servant of the Year, Finalist 2022
Westmead Institute Scientific Excellence (WISE Award) 2018